Besides we authenticate a novel gene IGF2BP2 is a credible marker and upregulated in PC, PCR and WB indicate that it promotes the B3GNT6 mRNA stability to contribute to the deterioration of PC, indicating that IGF2BP2 is a potential prognostic marker and therapeutic target in PC progression. Here, B3GNT6 is linked to pachyonychia congenita.